Signal tranducers and activators of transcription: Expression and function in anti‑neutrophil cytoplasmic antibody‑associated vasculitis

Wilde,Benjamin; Hoerning,André; Kribben,Andreas; Witzke,Oliver; Dolff,Sebastian

doi:10.3892/mmr.2014.2062

Signal tranducers and activators of transcription: Expression and function in anti‑neutrophil cytoplasmic antibody‑associated vasculitis

Authors:
- Benjamin Wilde
- André Hoerning
- Andreas Kribben
- Oliver Witzke
- Sebastian Dolff
View Affiliations

Affiliations: Department of Nephrology, University Hospital Essen, University of Duisburg‑Essen, Essen, North Rhine‑Westphalia 45122, Germany, Department of Pediatrics II, Pediatric Nephrology, Gastroenterology, Endocrinology and Transplant Medicine, Children's Hospital Essen, University of Duisburg‑Essen, Essen, North Rhine‑Westphalia 45122, Germany
Published online on: March 20, 2014 https://doi.org/10.3892/mmr.2014.2062
Pages: 2316-2320

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Anti‑neutrophil cytoplasmic antibody‑associated vasculitis (AAV) is an autoimmune small vessel vasculitis. Despite the role of autoantibodies, T cells play an essential role in pathogenesis and are abnormal in AAV. Signal transducers and activators of transcription (STAT) affect immunoregulation and T‑cell homeostasis. Therefore, the present study examined the ex vivo basal expression of the activated forms of STAT5 [phosphorylated (p)STAT5] and STAT3 (pSTAT3) in AAV and analyzed the function of two signaling pathways linked to these transcription factors. In total, 31 patients with AAV and 16 age‑matched healthy controls (HCs) were enrolled. CD3+ T cells from peripheral blood were analyzed directly ex vivo by a fluorescence‑activated cell sorter for basal expression of pSTAT5 and pSTAT3. Expression was also analyzed in T cells following short‑term stimulation with interleukin (IL)‑2 or ‑10. The basal expression of pSTAT5/3 in T cells was similar to AAV patients and HC. Following stimulation with IL-2 or -10, expression of pSTAT5/3 increased in AAV subjects compared with HC. Basal expression of pSTAT3 correlated with the relapse rate in AAV. In conclusion, STAT3 and STAT5 mediated signaling pathways were functionally intact in AAV patients and exhibited hyper‑responsiveness to IL‑2 and ‑10 stimuli. Thus, T‑cell abnormalities in AAV are not promoted by an altered basal expression of pSTAT5/3 or dysfunction of the IL‑2/‑10 signaling pathways, in which STAT5/3 are essential.

View Figures

View References

1	Wilde B, van Paassen P, Witzke O and Tervaert JW: New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 79:599–612. 2011. View Article : Google Scholar : PubMed/NCBI
2	Wilde B, Thewissen M, Damoiseaux J, van Paassen P, Witzke O and Tervaert JW: T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther. 12:2042010. View Article : Google Scholar : PubMed/NCBI
3	Brouwer E, Tervaert JW, Horst G, et al: Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders. Clin Exp Immunol. 83:379–386. 1991.PubMed/NCBI
4	Wilde B, van Paassen P, Damoiseaux J, et al: Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 24:2151–2156. 2009. View Article : Google Scholar : PubMed/NCBI
5	Lamprecht P, Moosig F, Csernok E, et al: CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener’s granulomatosis. Thorax. 56:751–757. 2001.PubMed/NCBI
6	Lamprecht P, Csernok E and Gross WL: Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener’s granulomatosis. J Intern Med. 260:187–191. 2006.PubMed/NCBI
7	Wilde B, Thewissen M, Damoiseaux J, et al: Th17 expansion in granulomatosis with polyangiitis (Wegener’s): the role of disease activity, immune regulation and therapy. Arthritis Res Ther. 14:R2272012.PubMed/NCBI
8	Wilde B, Hua F, Dolff S, et al: Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis. Rheumatology. 51:1188–1197. 2012. View Article : Google Scholar : PubMed/NCBI
9	Wilde B, Dolff S, Cai X, et al: CD4⁺CD25⁺ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener’s granulomatosis. Nephrol Dial Transplant. 24:161–171. 2009.PubMed/NCBI
10	Stegeman CA, Tervaert JW, Huitema MG and Kallenberg CG: Serum markers of T cell activation in relapses of Wegener’s granulomatosis. Clin Exp Immunol. 91:415–420. 1993.
11	Popa ER, Stegeman CA, Bos NA, Kallenberg CG and Tervaert JW: Differential B- and T-cell activation in Wegener’s granulomatosis. J Allergy Clin Immunol. 103:885–894. 1999.PubMed/NCBI
12	Marinaki S, Kälsch AI, Grimminger P, et al: Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol Dial Transplant. 21:1825–1832. 2006. View Article : Google Scholar : PubMed/NCBI
13	Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC and Kallenberg CG: Functional defect of circulating regulatory CD4⁺ T cells in patients with Wegener’s granulomatosis in remission. Arthritis Rheum. 56:2080–2091. 2007. View Article : Google Scholar : PubMed/NCBI
14	Free ME, Bunch DO, McGregor JA, et al: ANCA-associated vasculitis patients have defective Treg function exacerbated by presence of a suppression-resistant effector population. Arthritis Rheum. 65:1922–1933. 2013. View Article : Google Scholar : PubMed/NCBI
15	O’Shea JJ and Plenge R: JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 36:542–550. 2012.PubMed/NCBI
16	Stark GR and Darnell J Jr: The JAK-STAT pathway at twenty. Immunity. 36:503–514. 2012. View Article : Google Scholar : PubMed/NCBI
17	Liao W, Lin JX and Leonard WJ: Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity. 38:13–25. 2013. View Article : Google Scholar : PubMed/NCBI
18	Yang XP, Ghoreschi K, Steward-Tharp SM, et al: Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol. 12:247–254. 2011. View Article : Google Scholar : PubMed/NCBI
19	Lovato P, Brender C, Agnholt J, et al: Constitutive STAT3 activation in intestinal T cells from patients with Crohn’s disease. J Biol Chem. 278:16777–16781. 2003.PubMed/NCBI
20	Durant L, Watford WT, Ramos HL, et al: Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity. 32:605–615. 2010. View Article : Google Scholar : PubMed/NCBI
21	Engelhardt KR, Shah N, Faizura-Yeop I, et al: Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 131:825–830. 2013. View Article : Google Scholar : PubMed/NCBI
22	Hellmich B, Flossmann O, Gross WL, et al: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 66:605–617. 2007. View Article : Google Scholar
23	Leavitt RY, Fauci AS, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 33:1101–1107. 1990.PubMed/NCBI
24	Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37:187–192. 1994. View Article : Google Scholar : PubMed/NCBI
25	Jennette JC, Falk RJ, Bacon PA, et al: 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65:1–11. 2013. View Article : Google Scholar : PubMed/NCBI
26	Far DF, Peyron JF, Imbert V and Rossi B: Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry. Cytometry. 15:327–334. 1994. View Article : Google Scholar : PubMed/NCBI
27	Morgan MD, Day CJ, Piper KP, et al: Patients with Wegener’s granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology. 130:64–73. 2010.
28	Marinaki S, Neumann I, Kälsch AI, et al: Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol. 140:181–191. 2005. View Article : Google Scholar : PubMed/NCBI